Title |
Health-related quality of life in cancer patients at the end of life, translation, validation, and longitudinal analysis of specific tools: study protocol for a randomized controlled trial
|
---|---|
Published in |
Trials, April 2012
|
DOI | 10.1186/1745-6215-13-39 |
Pubmed ID | |
Authors |
Anne-Lise Poirier, Fabrice Kwiatkowski, Jean-Marie Commer, Bénédicte D'Aillières, Virginie Berger, Mariette Mercier, Franck Bonnetain |
Abstract |
The end of life for cancer patients is the ultimate stage of the disease, and care in this setting is important as it can improve the wellbeing not only of patients, but also the patients' family and close friends. As it is a matter of profoundly personal concerns, patients' perception of this phase of the disease is difficult to assess and has thus been insufficiently studied. Nonetheless, caregivers are required to provide specific care to help patients and to treat them in order to improve their wellbeing during this period.While tools to assess health-related quality of life (QoL) in cancer patients at the end of life exist in English, to our knowledge, no validated tools are available in French. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Mexico | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 1% |
United States | 1 | 1% |
Bangladesh | 1 | 1% |
Nigeria | 1 | 1% |
Unknown | 69 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 13 | 18% |
Researcher | 8 | 11% |
Student > Ph. D. Student | 7 | 10% |
Student > Bachelor | 5 | 7% |
Student > Postgraduate | 5 | 7% |
Other | 11 | 15% |
Unknown | 24 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 22 | 30% |
Nursing and Health Professions | 14 | 19% |
Agricultural and Biological Sciences | 2 | 3% |
Social Sciences | 2 | 3% |
Psychology | 2 | 3% |
Other | 3 | 4% |
Unknown | 28 | 38% |